Nivolumab-induced myocardial necrosis in a patient with lung cancer: A case report

被引：10

作者：

Sakai, Takashi ^{[1
,2
]}

Yahagi, Kazuyuki ^{[3
]}

Hoshino, Tatsuhiro ^{[1
]}

Yokota, Toshiya ^{[1
]}

Tanabe, Kengo ^{[3
]}

Mori, Masaya ^{[4
]}

Ikeda, Shingo ^{[1
]}

机构：

[1] Mitsui Mem Hosp, Div Thorac Surg, Chiyoda Ku, Kanda Izumicho 1, Tokyo 1018643, Japan

[2] Toho Univ, Grad Sch Med, Dept Surg, Div Chest Surg,Ota Ku, 6-11-1 Omorinishi, Tokyo 1438541, Japan

[3] Mitsui Mem Hosp, Div Cardiol, Chiyoda Ku, Kanda Izumicho 1, Tokyo 1018643, Japan

[4] Mitsui Mem Hosp, Div Pathol, Chiyoda Ku, Kanda Izumicho 1, Tokyo 1018643, Japan

来源：

RESPIRATORY MEDICINE CASE REPORTS | 2019年 / 27卷

关键词：

Nivolumab; Cardiotoxicity; Immune-related adverse events; DILATED CARDIOMYOPATHY; IMMUNE;

D O I：

10.1016/j.rmcr.2019.100839

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

A 74-year-old man with lung adenocarcinoma recurrence was admitted to our hospital because of dyspnea 7 days after receiving initial immunotherapy with nivolumab. Electrocardiography revealed ST-segment elevation in V1-6 and echocardiography showed a markedly reduced left ventricular ejection fraction of 9% and akinesis of the anteroseptal wall and apex. He died from acute heart failure 3 days after admission. Microscopically, multiple small foci of myocardial necrosis with few inflammatory cells were scattered in both ventricles. Obstruction of the coronary artery was not identified. We believed that the cause of death was acute heart failure possibly due to nivolumab-induced myocardial necrosis.

引用

页数：4

共 13 条

[1] PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo [J].

Chikuma, Shunsuke ;

Terawaki, Seigo ;

Hayashi, Tamon ;

Nabeshima, Ryusuke ;

Yoshida, Takao ;

Shibayama, Shiro ;

Okazaki, Taku ;

Honjo, Tasuku .

JOURNAL OF IMMUNOLOGY, 2009, 182 (11) :6682-6689

[2] Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity [J].

Escudier, Marion ;

Cautela, Jennifer ;

Malissen, Nausicaa ;

Ancedy, Yann ;

Orabona, Morgane ;

Pinto, Johan ;

Monestier, Sandrine ;

Grob, Jean-Jacques ;

Scemama, Ugo ;

Jacquier, Alexis ;

Lalevee, Nathalie ;

Barraud, Jeremie ;

Peyrol, Michael ;

Laine, Marc ;

Bonello, Laurent ;

Paganelli, Franck ;

Cohen, Ariel ;

Barlesi, Fabrice ;

Ederhy, Stephane ;

Thuny, Franck .

CIRCULATION, 2017, 136 (21) :2085-2087

[3] Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy [J].

Heinzerling, Lucie ;

Ott, Patrick A. ;

Hodi, F. Stephen ;

Husain, Aliya N. ;

Tajmir-Riahi, Azadeh ;

Tawbi, Hussein ;

Pauschinger, Matthias ;

Gajewski, Thomas F. ;

Lipson, Evan J. ;

Luke, Jason J. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4

[4] Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade [J].

Iwai, Y ;

Ishida, M ;

Tanaka, Y ;

Okazaki, T ;

Honjo, T ;

Minato, N .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12293-12297

[5] Fulminant Myocarditis with Combination Immune Checkpoint Blockade [J].

Johnson, Douglas B. dbj ;

Balko, Justin M. jmb ;

Compton, Margaret L. mlc ;

Chalkias, Spyridon sc ;

Gorham, Joshua jc ;

Xu, Yaomin yx ;

Hicks, Mellissa mh ;

Puzanov, Igor ip ;

Alexander, Matthew R. mra ;

Bloomer, Tyler L. tlb ;

Becker, Jason R. jrb ;

Slosky, David A. das ;

Phillips, Elizabeth J. ejp ;

Pilkinton, Mark A. map ;

Craig-Owens, Laura lco ;

Kola, Nina nk ;

Plautz, Gregory gp ;

Reshef, Daniel S. dsr ;

Deutsch, Jonathan S. jsd ;

Deering, Raquel P. rpd ;

Olenchock, Benjamin A. bao ;

Lichtman, Andrew H. ahl ;

Roden, Dan M. dmr ;

Seidman, Christine E. ces ;

Koralnik, Igor J. ijk ;

Seidman, Jonathan G. jgs ;

Hoffman, Robert D. rdh ;

Taube, Janis M. jmt ;

Diaz, Luis A. Jr lad ;

Anders, Robert A. raa ;

Sosman, Jeffrey A. jas ;

Moslehi, Javid J. jjm .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (18) :1749-1755

[6] Myocarditis in Patients Treated With Immune Checkpoint Inhibitors [J].

Mahmood, Syed S. ;

Fradley, Michael G. ;

Cohen, Justine V. ;

Nohria, Anju ;

Reynolds, Kerry L. ;

Heinzerling, Lucie M. ;

Sullivan, Ryan J. ;

Damrongwatanasuk, Rongras ;

Chen, Carol L. ;

Gupta, Dipti ;

Kirchberger, Michael C. ;

Awadalla, Magid ;

Hassan, Malek Z. O. ;

Moslehi, Javid J. ;

Shah, Sachin P. ;

Ganatra, Sarju ;

Thavendiranathan, Paaladinesh ;

Lawrence, Donald P. ;

Groarke, John D. ;

Neilan, Tomas G. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (16) :1755-1764

[7] Immune-related adverse events with immune checkpoint blockade: a comprehensive review [J].

Michot, J. M. ;

Bigenwald, C. ;

Champiat, S. ;

Collins, M. ;

Carbonnel, F. ;

Postel-Vinay, S. ;

Berdelou, A. ;

Varga, A. ;

Bahleda, R. ;

Hollebecque, A. ;

Massard, C. ;

Fuerea, A. ;

Ribrag, V. ;

Gazzah, A. ;

Armand, J. P. ;

Amellal, N. ;

Angevin, E. ;

Noel, N. ;

Boutros, C. ;

Mateus, C. ;

Robert, C. ;

Soria, J. C. ;

Marabelle, A. ;

Lambotte, O. .

EUROPEAN JOURNAL OF CANCER, 2016, 54 :139-148

[8] Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis [J].

Moslehi, Javid J. ;

Salem, Joe-Elie ;

Sosman, Jeffrey A. ;

Lebrun-Vignes, Benedicte ;

Johnson, Douglas B. .

LANCET, 2018, 391 (10124) :933-933

[9] Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice [J].

Nishimura, H ;

Okazaki, T ;

Tanaka, Y ;

Nakatani, K ;

Hara, M ;

Matsumori, A ;

Sasayama, S ;

Mizoguchi, A ;

Hiai, H ;

Minato, N ;

Honjo, T .

SCIENCE, 2001, 291 (5502) :319-322

[10] Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice [J].

Okazaki, T ;

Tanaka, Y ;

Nishio, R ;

Mitsuiye, T ;

Mizoguchi, A ;

Wang, J ;

Ishida, M ;

Hiai, H ;

Matsumori, A ;

Minato, N ;

Honjo, T .

NATURE MEDICINE, 2003, 9 (12) :1477-1483

← 1 2 →